Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

Sara Lodi; Martin Fisher; Andrew Phillips; Andrea De Luca; Jade Ghosn; Ruslan Malyuta; Robert Zangerle; Santiago Moreno; Philippe Vanhems; Faroudy Boufassa; Marguerite Guiguet; Kholoud Porter

doi:10.1371/journal.pone.0078642

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

Sara Lodi, Martin Fisher, Andrew Phillips, Andrea De Luca, Jade Ghosn, Ruslan Malyuta, Robert Zangerle, Santiago Moreno, Philippe Vanhems, Faroudy Boufassa, Marguerite Guiguet, Kholoud Porter

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

6 Citazioni (Scopus)

Abstract

The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.

Lingua originale	English
pagine (da-a)	e78642-e78642
Rivista	PLoS One
Volume	8
DOI	https://doi.org/10.1371/journal.pone.0078642
Stato di pubblicazione	Pubblicato - 2013

Keywords

CD4
drugs
hiv
markers

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1371/journal.pone.0078642

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{d3c2b1811f404b7ebcd1ade4e09c11f7,

title = "Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection",

abstract = "The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.",

keywords = "CD4, drugs, hiv, markers, CD4, drugs, hiv, markers",

author = "Sara Lodi and Martin Fisher and Andrew Phillips and {De Luca}, Andrea and Jade Ghosn and Ruslan Malyuta and Robert Zangerle and Santiago Moreno and Philippe Vanhems and Faroudy Boufassa and Marguerite Guiguet and Kholoud Porter",

year = "2013",

doi = "10.1371/journal.pone.0078642",

language = "English",

volume = "8",

pages = "e78642--e78642",

journal = "PLoS One",

issn = "1932-6203",

publisher = "San Francisco, CA : Public Library of Science",

}

TY - JOUR

T1 - Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

AU - Lodi, Sara

AU - Fisher, Martin

AU - Phillips, Andrew

AU - De Luca, Andrea

AU - Ghosn, Jade

AU - Malyuta, Ruslan

AU - Zangerle, Robert

AU - Moreno, Santiago

AU - Vanhems, Philippe

AU - Boufassa, Faroudy

AU - Guiguet, Marguerite

AU - Porter, Kholoud

PY - 2013

Y1 - 2013

N2 - The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.

AB - The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.

KW - CD4

KW - drugs

KW - hiv

KW - markers

KW - CD4

KW - drugs

KW - hiv

KW - markers

UR - http://hdl.handle.net/10807/54174

U2 - 10.1371/journal.pone.0078642

DO - 10.1371/journal.pone.0078642

M3 - Article

SN - 1932-6203

VL - 8

SP - e78642-e78642

JO - PLoS One

JF - PLoS One

ER -

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo